Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report

CVIR Endovascular

Julian Maingard¹  Geetha Guduguntla²  Shivendra Lalloo²  Dylan Kurda²  Hong Kuan Kok³ 

[1] Interventional Radiology, Austin Health;Interventional Radiology, The Canberra Hospital;School of Medicine, Deakin University, Waurn Ponds;

关键词: Embolization;    PHIL;    Uterine artery;    AVM;   

DOI  :  10.1186/s42155-019-0059-z

来源: DOAJ

【 摘 要 】

Abstract Objective Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. Case report A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8 weeks after the procedure. Conclusion Uterine AVM can be treated safely and effectively with UAE using PHIL.

【 授权许可】

Unknown